CP3 Director Dr. Walid Gellad spoke with The Atlantic about Paxlovid uncertainties and lack of information on how well it works in people who are vaccinated. “We really know nothing about the magnitude of its benefit or its risk in people who are vaccinated, let alone triple or quadruple vaccinated,” he said.